Skip to main content
CivicGate

HR 4396
Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.

Uterine Cancer Study Act of 2025

To direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color.

Introduced Jul 15, 2025

Latest action (Jul 15, 2025) Referred to the House Committee on Energy and Commerce.

Policy area
Issues
Healthcare

Summary

The bill directs the Secretary of Health and Human Services, working with the FDA and National Institutes of Health, to conduct a study on the relationship between chemical hair straighteners and uterine cancer, with particular attention to the higher incidence of the disease among women of color. The study will review existing research, examine health impacts across different racial and ethnic populations, and analyze whether straighteners containing different substances such as dyes, bleach, or perms present different levels of risk. The Secretary must submit a study methodology within 45 days of enactment and begin the research within 180 days. The study will also evaluate whether the FDA should require additional safety testing for hair straightening product manufacturers. A final report on the findings must be submitted to Congress within two years.

AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.

Sponsor (1)

Actions (2)

  1. Jul 15, 2025 Referred to the House Committee on Energy and Commerce. · house
  2. Jul 15, 2025 Introduced in House

Similar bills (6)

Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.

Text versions (1)

  • Introduced in House · Jul 15, 2025

Only one text version is on file, so there’s no earlier version to compare against yet.

Full text

IN THE HOUSE OF REPRESENTATIVES

July 15, 2025

Ms. Clarke of New York (for herself, Ms. Brown, Mrs. Watson Coleman, Ms. Kelly of Illinois, Mr. David Scott of Georgia, Ms. Norton, Ms. Sewell, Mrs. Foushee, Ms. McClellan, Ms. Velazquez, Mr. Fields, Mrs. Dingell, Ms. Tlaib, Mrs. Trahan, Mr. Johnson of Georgia, Ms. Ansari, Mr. Thanedar, Mr. Thompson of Mississippi, Mr. Krishnamoorthi, Ms. Salinas, Mrs. McIver, Mr. Carter of Louisiana, Ms. Wilson of Florida, Ms. Lee of Pennsylvania, Ms. Wasserman Schultz, Mr. Figures, Ms. Adams, Mr. Khanna, Mr. Meeks, Mr. Green of Texas, Ms. Tokuda, Ms. Rivas, and Mr. Mannion) introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To direct the Secretary of Health and Human Services to study and report on the relationship between hair straighteners and uterine cancer, particularly among women of color.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

This Act may be cited as the “Uterine Cancer Study Act of 2025”.

SEC. 2. STUDY ON RELATIONSHIP BETWEEN HAIR STRAIGHTENERS AND UTERINE CANCER.

(a) Study.—The Secretary of Health and Human Services, in coordination with the Commissioner of Food and Drugs and the Director of the National Institutes of Health, shall conduct a study on the relationship between hair straighteners and uterine cancer, with a focus on the increased incidence of such cancer among women of color. Such study shall—

(1) review significant findings and recommendations from other studies regarding the relationship between hair straighteners and uterine cancer;

(2) consider impacts on women and other individuals at risk of uterine cancer from all racial and ethnic backgrounds;

(3) disaggregate the results of the study under this section according to whether the hair straighteners contain dyes or coloring, bleach, highlights, or perms; and

(4) determine whether the Food and Drug Administration should impose additional testing requirements on the manufacturers of hair straightening products to ensure the safety of such products.

(b) Methodology.—Not later than 45 days after the date of enactment of this Act, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a description of the methodology that will be used to conduct the study under this section.

(c) Commencement.—Not later than 180 days after the date of enactment of this Act, the Secretary shall commence the study under this section.

(d) Report.—Not later than 2 years after the date of enactment of this Act, the Secretary shall complete the study under this section and submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the results of such study.

(e) Definition.—In this section:

(1) The term “hair straightener” means a chemical hair straightener.

(2) The term “Secretary” means the Secretary of Health and Human Services. <all>

Comments

Comments

Loading comments…